NEW
YORK, Feb. 20, 2025 /PRNewswire/ -- The
Gross Law Firm issues the following notice to shareholders of
Merck & Co., Inc. (NYSE: MRK).
Shareholders who purchased shares of MRK during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/?id=130545&from=4
CLASS PERIOD: February 3,
2022 to February 3, 2025
ALLEGATIONS: According to the complaint, defendants
provided investors with material information concerning Merck's
expected revenue of $11 billion from
sales of Gardasil by 2030. Defendants' statements included, among
other things, confidence in Merck's purported ability to utilize
successful consumer activation and education efforts on the
benefits of Gardasil in order to drive demand and capitalize on
eligible populations for vaccination, resulting in confidently
optimistic reports and forecasts of Gardasil's growth in
China. The full truth finally emerged on February 4, 2025, when Merck announced it would
no longer achieve the long-forecasted $11
billion in sales of Gardasil by 2030, as it would cease
shipments of Gardasil to China
"through at least midyear" to facilitate a "rapid reduction of
inventory." Defendants claimed this was necessitated by the
continued over-inflation of overall channel inventories as demand
in China for Gardasil had "not
recovered to the level we had expected." Following this news,
Merck's common stock declined dramatically. From a closing market
price of $99.79 per share on
February 3, 2025, Merck's stock price
fell to $90.74 per share on
February 4, 2025, a decline of more
than 9% in the span of just a single day.
DEADLINE: April 14, 2025
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/?id=130545&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of MRK during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is April 14, 2025. There is no cost or obligation to
you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/merck--co-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-april-14-2025-to-discuss-your-rights--mrk-302380875.html
SOURCE The Gross Law Firm
